Clinical trials in Brandenburg An Der Havel – page 3

Innovative research focusing on inflammatory bowel diseases, including multiple trials investigating novel treatments for ulcerative colitis and Crohn's disease. Studies are evaluating new therapeutic approaches with compounds like eltrekibart, rosnilimab, and obefazimod.

• Ulcerative Colitis Treatment Advances
• Crohn's Disease Management
• Eosinophilic Esophagitis Research

Additional investigations include treatments for gastroparesis and irritable bowel syndrome, exploring both conventional and innovative therapeutic approaches.

Comprehensive research in cancer treatments with a focus on blood cancers and solid tumors. Key studies include evaluation of combination therapies for mantle cell lymphoma and advanced treatment approaches for ovarian cancer.

• Lymphoma Treatments
• Ovarian Cancer Therapy
• Esophageal Cancer Management

Trials are investigating innovative drug combinations and immunotherapy approaches to improve patient outcomes.

Important investigations in cardiovascular health and kidney disease, including studies on reducing recurrent cardiovascular events post-heart attack and managing chronic kidney disease with hypertension.

• Post-Heart Attack Care
• Chronic Kidney Disease Management
• Hypertension Treatment

Research focuses on novel therapeutic combinations and preventive strategies for better patient outcomes.